7.10
Schlusskurs vom Vortag:
$7.06
Offen:
$7
24-Stunden-Volumen:
417.81K
Relative Volume:
0.70
Marktkapitalisierung:
$604.41M
Einnahmen:
$81.18M
Nettoeinkommen (Verlust:
$-80.94M
KGV:
-6.0124
EPS:
-1.1809
Netto-Cashflow:
$-55.15M
1W Leistung:
-2.74%
1M Leistung:
-10.80%
6M Leistung:
+40.04%
1J Leistung:
+65.50%
Sophia Genetics Sa Stock (SOPH) Company Profile
Firmenname
Sophia Genetics Sa
Sektor
Branche
Telefon
-
Adresse
-
Compare SOPH vs VEEV, TEM, BTSG, HNGE, HQY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
SOPH
Sophia Genetics Sa
|
7.10 | 604.41M | 81.18M | -80.94M | -55.15M | -1.1809 |
|
VEEV
Veeva Systems Inc
|
312.46 | 50.59B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
TEM
Tempus Ai Inc
|
69.08 | 12.54B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
BTSG
Brightspring Health Services Inc
|
62.41 | 12.35B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
HNGE
Hinge Health Inc
|
105.36 | 8.50B | 646.34M | -512.40M | 202.76M | -6.6871 |
|
HQY
Healthequity Inc
|
92.42 | 7.64B | 1.34B | 230.70M | 440.96M | 2.6695 |
Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-07-20 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-12-18 | Eingeleitet | Craig Hallum | Buy |
| 2024-08-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-06-27 | Eingeleitet | Guggenheim | Buy |
| 2023-11-29 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-01-03 | Eingeleitet | BTIG Research | Buy |
| 2022-11-23 | Eingeleitet | Credit Suisse | Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-17 | Eingeleitet | Cowen | Outperform |
| 2021-08-17 | Eingeleitet | Credit Suisse | Outperform |
| 2021-08-17 | Eingeleitet | JP Morgan | Overweight |
| 2021-08-17 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Sophia Genetics Sa Aktie (SOPH) Neueste Nachrichten
SOPHiA GENETICS SA Ordinary Shares (SOPH) Stock Price: Oct 7 Close $7.15 - Gotrade
SOPHiA GENETICS CSO Kevin Puylaert Sells 216 Shares for RSU Tax Withholding on October 5, 2026 - Kalkine Media
SOPHiA GENETICS CMO Philippe Menu Sells 7,394 Shares to Cover RSU Tax Withholdings - Kalkine Media
SOPHiA GENETICS (NASDAQ:SOPH) Insider Well Daan Van Sells 6,168 Shares of Company Stock - MarketBeat
Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells 7,394 Shares of Company Stock - MarketBeat
Tax withholding drives legal chief’s 6,168-share sale at SOPHiA GENETICS (SOPH) - Stock Titan
SOPHiA GENETICS Director Ross J. Muken Files Form 144 for Sale of 9,838 Shares Under 10b5-1 Plan - Kalkine Media
An officer plans to sell 19,394 common shares in SOPHiA GENETICS (SOPH). - Stock Titan
An officer proposes selling 6,168 SOPHiA GENETICS (NASDAQ: SOPH) shares after stock grants vest. - Stock Titan
9,838 shares are proposed for sale by Ross J. Muken at SOPHiA GENETICS (SOPH), valued at $79.4K. - Stock Titan
Officer George Cardoza proposes selling 1,592 SOPHiA GENETICS (SOPH) common shares. - Stock Titan
Founder shares feature in Jurgi Camblong’s proposed $530K SOPHiA GENETICS (Nasdaq: SOPH) sale. - Stock Titan
SOPHiA GENETICS CEO Ross Muken Sells 422 Shares to Cover RSU Tax Withholding - Kalkine Media
SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to Purchase Additional Shares - Eastern Progress
Officer at SOPHiA GENETICS (NASDAQ: SOPH) lines up 774-share sale after 10b5-1 trades - Stock Titan
Planned sale of 422 SOPHiA GENETICS (SOPH) shares disclosed under Rule 144 - Stock Titan
SOPHiA GENETICS (SOPH) Moves 7.0% Higher: Will This Strength Last? - Yahoo Finance
SOPHiA GENETICS (NASDAQ: SOPH) Insider Xu Zhenyu Retains 552,887 Shares Following Sale - Kalkine Media
SOPHiA GENETICS SA (NASDAQ: SOPH) Executive Menu Philippe Disposes of 5,000 Shares at $7.88 Each - Kalkine Media
SOPHiA GENETICS CSO Xu Zhenyu Sells 4,000 Shares Under Rule 10b5-1 Plan - Kalkine Media
SOPHiA GENETICS (NASDAQ:SOPH) Sees Strong Trading VolumeShould You Buy? - marketbeat.com
SOPHiA GENETICS Insider Van Well Daan Sells 6,168 Shares at $7.63 Each (NASDAQ: SOPH) - Kalkine Media
Officer at SOPHiA GENETICS (NASDAQ: SOPH) to sell 6,168 shares - Stock Titan
SOPHiA GENETICS SA (NASDAQ:SOPH) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) Director Sells $50,812.50 in Stock - MarketBeat
SOPHiA GENETICS Director Kathy L. Hibbs Sells 6,250 Shares via 10b5-1 Trading Plan - Kalkine Media
SOPHiA GENETICS (NASDAQ:SOPH) Shares Down 8.3%Time to Sell? - MarketBeat
Maven Securities LTD Invests $866,000 in SOPHiA GENETICS SA $SOPH - MarketBeat
SOPHiA GENETICS (SOPH) Stock Sees Modest Fair Value Lift After Q2 Guidance Raise - Yahoo Finance
SOPHiA GENETICS (NASDAQ:SOPH): Is Volume Signaling A Shift? - Kalkine Media
SOPHiA GENETICS (NASDAQ:SOPH) Sees Large Volume IncreaseHere's Why - marketbeat.com
SOPHiA GENETICS CSO Zhenyu Xu Sells 10,000 Shares Under Rule 10b5-1 Plan - Kalkine Media
Zhenyu Xu Sells 10,000 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock - MarketBeat
SOPHiA GENETICS (NASDAQ:SOPH) Stock Price Down 5%Here's Why - MarketBeat
Sophia Genetics SA (SOPH) Peer Comparison – Compare with Others - Value Research
SOPHiA GENETICS (NASDAQ: SOPH) officer to sell 14K founder shares - Stock Titan
SOPHiA GENETICS Director Kathy L. Hibbs Sells 6,250 Shares Under Rule 10b5-1 Plan - Kalkine Media
SOPHiA GENETICS CTO Abhimanyu Verma Executes Sale of 10,000 Shares in August 2026 - Kalkine Media
SOPHiA GENETICS (NASDAQ: SOPH) director plans $158K stock sale - Stock Titan
SOPHiA (SOPH) Earnings Update: The Available Earnings Metric Delivers a Miss in the Available Record; Share Move: Shares Move Lower 2.31% in Latest TradingEarnings Stability Report - dars.gov.et
SOPHiA GENETICS (NASDAQ:SOPH) Sees Strong Trading VolumeHere's What Happened - marketbeat.com
SOPHiA (SOPH) Earnings Update: The Available Earnings Metric Delivers a Miss in the Available Record; Share Move - careplusvn.com
SOPHiA (SOPH) Earnings Update: The Available Earnings Metric Delivers a Miss in the Available Record; Share Move: Shares Move Lower 2.31% in Latest TradingRevenue Surprise History - dars.gov.et
SOPHiA GENETICS Chief Scientific Officer Xu Zhenyu Sells 20,000 Shares Over Three Days - Kalkine Media
SOPHiA GENETICS CPO Manuela Valente Executes Share Option Exercise and Sale - Kalkine Media
SOPHiA GENETICS (NASDAQ: SOPH) officer may sell founder shares - Stock Titan
SOPHiA GENETICS (NASDAQ: SOPH) officer lines up 10,000-share sale - Stock Titan
SOPHiA GENETICS (NASDAQ: SOPH) officer plans additional 8,000-share sale - Stock Titan
SOPHiA GENETICS (NASDAQ:SOPH) Hits New 12-Month HighShould You Buy? - MarketBeat
EBIT per share of SOPHiA GENETICS SA – DUS:90B - TradingView
Finanzdaten der Sophia Genetics Sa-Aktie (SOPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
Sophia Genetics Sa-Aktie (SOPH) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Xu Zhenyu | Chief Scientific Officer |
Oct 13 '26 |
Sale |
7.18 |
4,000 |
28,727 |
541,493 |
| Camblong Jurgi | Executive Chairman |
Oct 12 '26 |
Sale |
7.26 |
8,500 |
61,671 |
3,387,150 |
| ROSS J MUKEN | Director |
Oct 05 '26 |
Proposed Sale |
8.07 |
9,838 |
79,393 |
0 |
| PHILIPPE MENU | Officer |
Oct 05 '26 |
Proposed Sale |
8.07 |
22,394 |
180,720 |
0 |
| MANUELA VALENTE | Officer |
Oct 05 '26 |
Proposed Sale |
8.07 |
4,240 |
34,217 |
0 |
| GEORGE CARDOZA | Officer |
Oct 05 '26 |
Proposed Sale |
8.07 |
1,592 |
12,847 |
0 |
| JURGI CAMBLONG | Director |
Oct 05 '26 |
Proposed Sale |
8.07 |
65,672 |
529,973 |
0 |
| Valente Manuela | Chief People Officer |
Oct 05 '26 |
Sale |
8.13 |
4,240 |
34,487 |
206,210 |
| Verma Abhimanyu | Chief Technology Officer |
Oct 05 '26 |
Sale |
8.12 |
5,284 |
42,929 |
166,887 |
| Van Well Daan | Chief Legal Officer |
Oct 05 '26 |
Sale |
8.12 |
6,168 |
50,100 |
332,716 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):